Magnetotactic Bacteria and Magnetosomes as Smart Drug Delivery Systems: A New Weapon on the Battlefield with Cancer?

被引:36
作者
Kuzajewska, Danuta [1 ]
Wszolek, Agata [1 ]
Zwierello, Wojciech [2 ]
Kirczuk, Lucyna [1 ]
Maruszewska, Agnieszka [1 ]
机构
[1] Univ Szczecin, Inst Biol, Felczaka 3c St, PL-71412 Szczecin, Poland
[2] Pomeranian Med Univ, Dept Med Chem, Powstancow Wlkp 71 St, PL-70111 Szczecin, Poland
来源
BIOLOGY-BASEL | 2020年 / 9卷 / 05期
关键词
Magnetotactic bacteria; magnetosomes; drug delivery systems; cancer; targeted therapy; MAGNETOSPIRILLUM-GRYPHISWALDENSE MSR-1; MAGNETIC NANOPARTICLES; CO-DELIVERY; CECROPIN B; IN-VITRO; GENE; DOXORUBICIN; CELLS; MECHANISMS; RESISTANCE;
D O I
10.3390/biology9050102
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
An important direction of research in increasing the effectiveness of cancer therapies is the design of effective drug distribution systems in the body. The development of the new strategies is primarily aimed at improving the stability of the drug after administration and increasing the precision of drug delivery to the destination. Due to the characteristic features of cancer cells, distributing chemotherapeutics exactly to the microenvironment of the tumor while sparing the healthy tissues is an important issue here. One of the promising solutions that would meet the above requirements is the use of Magnetotactic bacteria (MTBs) and their organelles, called magnetosomes (BMs). MTBs are commonly found in water reservoirs, and BMs that contain ferromagnetic crystals condition the magnetotaxis of these microorganisms. The presented work is a review of the current state of knowledge on the potential use of MTBs and BMs as nanocarriers in the therapy of cancer. The growing amount of literature data indicates that MTBs and BMs may be used as natural nanocarriers for chemotherapeutics, such as classic anti-cancer drugs, antibodies, vaccine DNA, and siRNA. Their use as transporters increases the stability of chemotherapeutics and allows the transfer of individual ligands or their combinations precisely to cancerous tumors, which, in turn, enables the drugs to reach molecular targets more effectively.
引用
收藏
页数:21
相关论文
共 104 条
[61]   Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity [J].
Minotti, G ;
Menna, P ;
Salvatorelli, E ;
Cairo, G ;
Gianni, L .
PHARMACOLOGICAL REVIEWS, 2004, 56 (02) :185-229
[62]   Magnetotactic Bacteria Penetration into Multicellular Tumor Spheroids for Targeted Therapy [J].
Mokrani, Nisryn ;
Felfoul, Ouajdi ;
Zarreh, Fatemeh Afkhami ;
Mohammadi, Mahmood ;
Aloyz, Raquel ;
Batist, Gerald ;
Martel, Sylvain .
2010 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2010, :4371-4374
[63]   Topoisomerases and Anthracyclines: Recent Advances and Perspectives in Anticancer Therapy and Prevention of Cardiotoxicity [J].
Mordente, Alvaro ;
Meucci, Elisabetta ;
Martorana, Giuseppe Ettore ;
Tavian, Daniela ;
Silvestrini, Andrea .
CURRENT MEDICINAL CHEMISTRY, 2017, 24 (15) :1607-1626
[64]   Comprehensive genetic dissection of the magnetosome gene island reveals the step-wise assembly of a prokaryotic organelle [J].
Murat, Dorothee ;
Quinlan, Anna ;
Vali, Hojatollah ;
Komeili, Arash .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (12) :5593-5598
[65]   The challenge of drug resistance in cancer treatment: a current overview [J].
Nikolaou, Michail ;
Pavlopoulou, Athanasia ;
Georgakilas, Alexandros G. ;
Kyrodimos, Efthymios .
CLINICAL & EXPERIMENTAL METASTASIS, 2018, 35 (04) :309-318
[66]   Structure prediction of magnetosome-associated proteins [J].
Nudelman, Hila ;
Zarivach, Raz .
FRONTIERS IN MICROBIOLOGY, 2014, 5
[67]   3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs [J].
Nunes, Ana S. ;
Barros, Andreia S. ;
Costa, Elisabete C. ;
Moreira, Andre F. ;
Correia, Ilidio J. .
BIOTECHNOLOGY AND BIOENGINEERING, 2019, 116 (01) :206-226
[68]  
Oh D, 2014, IEEE ENG MED BIO, P1390, DOI 10.1109/EMBC.2014.6943859
[69]   Advances in the synthesis and application of nanoparticles for drug delivery [J].
Park, Wooram ;
Na, Kun .
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY, 2015, 7 (04) :494-508
[70]   Nanoparticles in Combating Cancer: Opportunities and Limitations: A Brief Review [J].
Pedziwiatr-Werbicka, Elzbieta ;
Horodecka, Katarzyna ;
Shcharbin, Dzmitry ;
Bryszewska, Maria .
CURRENT MEDICINAL CHEMISTRY, 2021, 28 (02) :346-359